These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18657398)

  • 1. Temporal relationship between change in cognition and change in functioning in schizophrenia.
    Fiszdon JM; Choi J; Goulet J; Bell MD
    Schizophr Res; 2008 Oct; 105(1-3):105-13. PubMed ID: 18657398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive function needs to be targeted to improve social functioning with Cognitive Remediation Therapy (CRT) in schizophrenia.
    Penadés R; Catalán R; Puig O; Masana G; Pujol N; Navarro V; Guarch J; Gastó C
    Psychiatry Res; 2010 May; 177(1-2):41-5. PubMed ID: 20381164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community dysfunction in schizophrenia: rate-limiting factors.
    Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior.
    Bowie CR; McGurk SR; Mausbach B; Patterson TL; Harvey PD
    Am J Psychiatry; 2012 Jul; 169(7):710-8. PubMed ID: 22581070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abbreviated quality of life scales for schizophrenia: comparison and utility of two brief community functioning measures.
    Fervaha G; Foussias G; Siddiqui I; Agid O; Remington G
    Schizophr Res; 2014 Apr; 154(1-3):89-92. PubMed ID: 24630140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting quality of life impairment in chronic schizophrenia from cognitive variables.
    Ritsner MS
    Qual Life Res; 2007 Aug; 16(6):929-37. PubMed ID: 17404898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in stable schizophrenia: the relative contributions of disorganization and cognitive dysfunction.
    Sigaudo M; Crivelli B; Castagna F; Giugiario M; Mingrone C; Montemagni C; Rocca G; Rocca P
    Schizophr Res; 2014 Mar; 153(1-3):196-203. PubMed ID: 24485197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of negative symptoms in the context of cognitive remediation for schizophrenia.
    Farreny A; Aguado J; Ochoa S; Haro JM; Usall J
    Schizophr Res; 2013 Oct; 150(1):58-63. PubMed ID: 23993864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
    Milev P; Ho BC; Arndt S; Andreasen NC
    Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive individualized training versus social skills individualized training: a randomized trial in patients with schizophrenia.
    Bucci P; Piegari G; Mucci A; Merlotti E; Chieffi M; De Riso F; De Angelis M; Di Munzio W; Galderisi S
    Schizophr Res; 2013 Oct; 150(1):69-75. PubMed ID: 23962828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of cognitive and functional improvement and normalization after cognitive remediation in patients with schizophrenia.
    Vita A; Deste G; De Peri L; Barlati S; Poli R; Cesana BM; Sacchetti E
    Schizophr Res; 2013 Oct; 150(1):51-7. PubMed ID: 23998953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive enhancement therapy with vocational services: work outcomes at two-year follow-up.
    Bell MD; Zito W; Greig T; Wexler BE
    Schizophr Res; 2008 Oct; 105(1-3):18-29. PubMed ID: 18715755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.
    Fan X; Henderson DC; Nguyen DD; Cather C; Freudenreich O; Evins AE; Borba CP; Goff DC
    Psychiatry Res; 2008 May; 159(1-2):140-6. PubMed ID: 18423611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REPYFLEC cognitive remediation group training in schizophrenia: Looking for an integrative approach.
    Farreny A; Aguado J; Ochoa S; Huerta-Ramos E; Marsà F; López-Carrilero R; Carral V; Haro JM; Usall J
    Schizophr Res; 2012 Dec; 142(1-3):137-44. PubMed ID: 23017827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic variables at intake and long-term level of function in schizophrenia.
    Siegel SJ; Irani F; Brensinger CM; Kohler CG; Bilker WB; Ragland JD; Kanes SJ; Gur RC; Gur RE
    Am J Psychiatry; 2006 Mar; 163(3):433-41. PubMed ID: 16513864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia patients with cognitive deficits: factors associated with costs.
    Patel A; Everitt B; Knapp M; Reeder C; Grant D; Ecker C; Wykes T
    Schizophr Bull; 2006 Oct; 32(4):776-85. PubMed ID: 16885205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.